- Summary
- Publications
- Research
- Media
- Locations
After attending medical school at Flinders University in Australia, Dr. Jaffray spent the next 6 years of her training on the east coast of the United States. She completed her pediatric residency at the University of Massachusetts and her pediatric hematology/oncology training at the combined Memorial Sloan Kettering Cancer Center/New York Presbyterian Hospital Weill Cornell program. In 2013 she returned to her home state of California to start a two year advanced fellowship in pediatric coagulation at Children’s Hospital Los Angeles under the guidance of Dr. Guy Young. Following the completion of her coagulation fellowship, she stayed at CHLA as a faculty hematologist specializing in pediatric diseases of hemostasis and thrombosis.
Clinical Interests
Thrombosis and Hemostasis
Education
Flinders University of South Australia
University of Massachusetts Memorial Medical Center
Memorial Sloan Kettering Cancer Center/New York-Presbyterian Hospital of the Weill Medical College of Cornell University
Accomplishments
Pediatric Hematology/Oncology 2015, Pediatrics 2012
American Society of Hematology 2011-present
American Society of Pediatric Hematology Oncology 2011-present
Hemostasis and Thrombosis Research Society 2012-present
World Federation of Haemophilia 2014-present
International Society on Thrombosis and Haemostasis 2014-present
American Thrombosis and Hemostasis Network 2014-present
Hemostasis & Thrombosis Research Society Abstract & Travel Award, 2015
Stephen M. Thompson Physician Corps Award Recipient, 2014
Hemophilia Academy Awardee, 2013
Hemostasis & Thrombosis Research Society Workshop Grant, 2012
American Society of Hematology Trainee Research Award, 2008
Jaffray, J. & Young, G. Recent trial results in recombinant coagulation factors for the treatment of hemophilia B. Clinical Investigation 2014; 5: 205-16.
Li, J., Hale, J., Bhagia, P., Xue, F., Chen, L., Jaffray, J., Yan, H., Lane, J., Gallagher, P.G., Mohandas, N., Liu, J., An, X. Isolation and transcription analyses of human erythroid progenitors: BFU-E and CFU-E. Blood 2014;124:3635-45.
Jaffray, J. & Young, G. Developmental Hemostasis: Clinical Implications from the Fetus to the Adolescent. Pediatric Clinics of North America 2013; 60 (6):1407-17.
Jaffray, J.A., Mitchell, W.B., Gnanapragasam, M.N., Seshan, S.V., Guo, X, Westhoff, C.M., Bieker, J.J., Manwani, D. Erythroid Transcription Factor EKLF/KLF1 Mutation Causing Congenital Dyserythropoietic Anemia in a Patient of Taiwanese Origin. Blood, Cells, Molecules and Diseases 2013; 51:71-75.
Hu, J., Liu, J., Xue, F., Halverson, G., Reid, M., Guo, A., Chen, L., Raza, A., Jaffray, J., Lane, J., Chasis, JA., Taylor, N., Narla, M., An, A. Isolation and functional characterization of human erythroblasts at distinct stages: implications for understanding of normal and disordered erythropoiesis in vivo, Blood 2013; 121: 3246-53.
Blood clot prevention in hospitalized children and those with central lines, as well as improving the care of girls and young women with bleeding disorders.